scispace - formally typeset
D

David L. DeMets

Researcher at University of Wisconsin-Madison

Publications -  314
Citations -  62465

David L. DeMets is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Clinical trial & Data monitoring committee. The author has an hindex of 81, co-authored 296 publications receiving 56109 citations. Previous affiliations of David L. DeMets include Duke University & Durham University.

Papers
More filters
Journal ArticleDOI

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework*

TL;DR: Biomarker measurements provide an avenue for researchers to gain a mechanistic understanding of the differences in clinical response that may be influenced by uncontrolled variables (for example, drug metabolism).
Journal ArticleDOI

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Åke Hjalmarson, +350 more
- 12 Jun 1999 - 
TL;DR: Metoprolol controlled release/extended release (CR/XL) once daily in addition to standard therapy improved survival and the drug was well tolerated.
Journal ArticleDOI

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

TL;DR: Among patients with heart failure and a reduced ejection fraction, the risk of worsening heart failure or death from cardiovascular causes was lower among those who received dapagliflozin than amongThose who received placebo, regardless of the presence or absence of diabetes.
Journal ArticleDOI

Effect of carvedilol on survival in severe chronic heart failure.

TL;DR: The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also apparent in the patients with severe heart failure who were evaluated in this trial.